SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Addressing the issues that arise in analysing multicentre cost data, with application to a multinational study
16 references·0 citing·48 second hop
Addressing the issues that arise in analysing multicentre cost data, with application to a multinational study (2006)Addressing the issues that arise in analy…Methods for incorporating covariate adjustment, subgroup analysis and between‐centre differences into cost‐effectiveness evaluations (2005)Methods for incorporating cov…How Sensitive Are Cost-Effectiveness Analyses to Choice of Parametric Distributions? (2005)How Sensitive Are Cost-Effect…Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel models (2004)Assessing generalisability by…Comparing alternative models: log vs Cox proportional hazard? (2003)Comparing alternative models:…Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality? (2002)Assessing and comparing costs…A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment. (2002)A comparison of methods to ha…How should cost data in pragmatic randomised trials be analysed? (2000)How should cost data in pragm…Cross-national price differences for pharmaceuticals: how large, and why? (2000)Cross-national price differen…The Distribution of Health Care Costs and Their Statistical Analysis for Economic Evaluation (1998)The Distribution of Health Ca…Much Ado About Two: Reconsidering Retransformation and the Two-Part Model in Health Economics (1998)Much Ado About Two: Reconside…Estimating country-specific cost-effectiveness from multinational clinical trials (1998)Estimating country-specific c…Detecting and describing heterogeneity in meta-analysis (1998)Detecting and describing hete…A tale of two (or more) cities: geographic transferability of pharmacoeconomic data. (1997)A tale of two (or more) citie…Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated (1994)Systematic Review: Why source…Frontier estimation: How useful a tool for health economics? (1994)Frontier estimation: How usef…Issues in the Cross-National Assessment of Health Technology (1992)Issues in the Cross-National …Meta-analysis in clinical trials (1986)Publication bias in clinical research (1991)Conducting systematic reviews of diagnostic studies: didactic guidelines (2002)Socioeconomic Inequalities in Depression: A Meta-Analysis (2003)Long-term mental health of war-refugees: a systematic literature review (2015)Practical statistics for medical research (1992)Cost-Effectiveness in Health and Medicine (1996)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Economic evaluation and clinical trials: size matters (2000)Costs and consequences of enhanced primary care for depression (2006)New models for old questions: generalized linear models for cost prediction (2007)Costs, effects and C/E‐ratios alongside a clinical trial (1994)Net Health Benefits (1998)The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)Statistical Methods for Cost-Effectiveness Analyses That Use Data from Cluster Randomized Trials (2011)Acknowledging Patient Heterogeneity in Economic Evaluation (2013)The statistical approach in trial-based economic evaluations matters: get your statistics together! (2021)A Theory of Yardstick Competition (1985)A Theory of Incentives in Procurement and Regulation (1993)A theory of incentives in procurement and regulation (1994)Measuring hospital efficiency: a comparison of two approaches. (2000)Stochastic Frontier Analysis of Hospital Inefficiency (2007)Potential gains from hospital mergers in Denmark (2010)The logged dependent variable, heteroscedasticity, and the retransformation problem (1998)Using the SF-12 Health Status Measure to Improve Predictions of Medical Expenditures (2006)Issues for the Next Generation of Health Care Cost Analyses (2009)Models for Health Care (2012)Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Methods for the economic evaluation of health care programmes (1987)Assessing the costs of healthcare technologies in clinical trials. (1999)Methods for the Economic Evaluation of Health Care Programmes (2005)Variability of Cost-Effectiveness Estimates for Pharmaceuticals in Western Europe: Lessons for Inferring Generalizability (2005)Nixon, Richard M. (1999)Development of WHO guidelines on generalized cost-effectiveness analysis (2000)Collecting unit cost data in multicentre studies (2004)The Economics of Priority Setting for Health Care : A Literature Review (2004)Male-Female Wage Differentials in Urban Labor Markets (1973)Labor Market Discrimination Against Hispanic and Black Men (1983)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Does Regulation Drive Out Competition in Pharmaceutical Markets? (2000)The Hedonic Method (2003)Parallel imports and the pricing of pharmaceutical products: evidence from the European Union (2004)Financial cost of social exclusion: follow up study of antisocial children into adulthood (2001)Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. (2008)Review of statistical methods for analysing healthcare resources and costs (2010)A refined method for the meta‐analysis of controlled clinical trials with binary outcome (2001)Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice (2002)Sex Differences in Insomnia: A Meta-Analysis (2006)
this work references cited by second hop

References

  • 1994Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated1,016 cited
  • 2000How should cost data in pragmatic randomised trials be analysed?771 cited
  • 1998Detecting and describing heterogeneity in meta-analysis728 cited
  • 2000Cross-national price differences for pharmaceuticals: how large, and why?285 cited
  • 1998The Distribution of Health Care Costs and Their Statistical Analysis for Economic Evaluation271 cited
  • 1994Frontier estimation: How useful a tool for health economics?256 cited
  • 2003Comparing alternative models: log vs Cox proportional hazard?169 cited
  • 1992Issues in the Cross-National Assessment of Health Technology160 cited
  • 2005Methods for incorporating covariate adjustment, subgroup analysis and between‐centre differences into cost‐effectiveness evaluations128 cited
  • 1998Estimating country-specific cost-effectiveness from multinational clinical trials125 cited
  • 2004Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel models117 cited
  • 2002Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?100 cited
  • 2002A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.98 cited
  • 1998

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Much Ado About Two: Reconsidering Retransformation and the Two-Part Model in Health Economics
94 cited
  • 1997A tale of two (or more) cities: geographic transferability of pharmacoeconomic data.82 cited
  • 2005How Sensitive Are Cost-Effectiveness Analyses to Choice of Parametric Distributions?80 cited
  • Cited by

    No citing works inside the corpus for this window.